These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nanotechnology-based platforms to improve immune checkpoint blockade efficacy in cancer therapy. G Lahori D; Varamini P Future Oncol; 2021 Feb; 17(6):711-722. PubMed ID: 33136464 [TBL] [Abstract][Full Text] [Related]
4. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy. Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610 [TBL] [Abstract][Full Text] [Related]
5. [Outline of treatment for colorectal cancer]. Kodaira S Nihon Rinsho; 2003 Sep; 61 Suppl 7():293-7. PubMed ID: 14574898 [No Abstract] [Full Text] [Related]
6. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma. Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035 [TBL] [Abstract][Full Text] [Related]
7. Current status of adjuvant therapy for colorectal cancer. O'Connell MJ Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594 [TBL] [Abstract][Full Text] [Related]
8. The treatment of colorectal carcinoma: standard chemotherapy and beyond. Eng C; Abbruzzese JL Clin Adv Hematol Oncol; 2004 Sep; 2(9):592-8. PubMed ID: 16163242 [TBL] [Abstract][Full Text] [Related]
9. Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG). Miyake Y; Nishimura J; Kato T; Ikeda M; Tsujie M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M; Surg Today; 2018 Jan; 48(1):66-72. PubMed ID: 28634730 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy of colorectal cancer: the next step forward. Prabhudesai AG; Kumar D Curr Med Res Opin; 2002; 18(5):249-57. PubMed ID: 12240786 [TBL] [Abstract][Full Text] [Related]
12. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004]. Medinger M; Steinbild S; Mross K Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy of cancers of the colon and rectum. Saltz LB; Minsky B Surg Clin North Am; 2002 Oct; 82(5):1035-58. PubMed ID: 12507208 [TBL] [Abstract][Full Text] [Related]
14. Surgical adjuvant therapy for colorectal cancer: current approaches and future directions. Monga DK; O'Connell MJ Ann Surg Oncol; 2006 Aug; 13(8):1021-34. PubMed ID: 16897272 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis. Serrano PE; Carter DN; Li C; Valencia M; Ruo L; Parpia S; Simunovic M; Levine O J Surg Res; 2019 Jul; 239():14-21. PubMed ID: 30782542 [TBL] [Abstract][Full Text] [Related]
16. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer. Krishnaiah YS; Khan MA Pharm Dev Technol; 2012; 17(5):521-40. PubMed ID: 22681390 [TBL] [Abstract][Full Text] [Related]